| Danish Zaidi, MD | |
|
2800 Clay Edwards Dr, North Kansas City, MO 64116-3220 | |
| (816) 221-4114 | |
| (816) 471-1247 |
| Full Name | Danish Zaidi |
|---|---|
| Gender | Male |
| Speciality | Pain Medicine - Interventional Pain Medicine |
| Location | 2800 Clay Edwards Dr, North Kansas City, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053846386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 2022017552 (Missouri) | Primary |
| Entity Name | Pain Source Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013018076 PECOS PAC ID: 0547241986 Enrollment ID: O20040601000320 |
News Archive
Maintaining a high negative pressure in airborne infection isolation rooms of hospitals (over -10 Pa) and in renovation sites (over -5 Pa) effectively limits the dispersion of airborne contaminants and dust, a new study from the University of Eastern Finland shows.
Indegene, a leading provider of R&D, commercial, and marketing solutions to top global pharmaceutical and healthcare organizations, today announced that its Multi-channel Marketing (MCM) division has launched a suite of Brand-Focused Solutions for the brand marketing teams.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of renal cell carcinoma (RCC), the majority of surveyed European oncologists who favor Pfizer's Sutent indicate that they would switch to an emerging therapy only if it extended progression-free survival (PFS) by at least an additional two to three months, assuming the agent's safety and tolerability profile was comparable to that of Sutent.
Researchers at the University of Massachusetts Medical School have described a previously unknown role for the cilia protein IFT88 in mitosis, the process by which a dividing cell separates its chromosomes containing the cell's DNA into two identical sets of new daughter cells.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danish Zaidi, MD Po Box 411099, Kansas City, MO 64141-1099 Ph: (816) 221-5050 | Danish Zaidi, MD 2800 Clay Edwards Dr, North Kansas City, MO 64116-3220 Ph: (816) 221-4114 |
News Archive
Maintaining a high negative pressure in airborne infection isolation rooms of hospitals (over -10 Pa) and in renovation sites (over -5 Pa) effectively limits the dispersion of airborne contaminants and dust, a new study from the University of Eastern Finland shows.
Indegene, a leading provider of R&D, commercial, and marketing solutions to top global pharmaceutical and healthcare organizations, today announced that its Multi-channel Marketing (MCM) division has launched a suite of Brand-Focused Solutions for the brand marketing teams.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of renal cell carcinoma (RCC), the majority of surveyed European oncologists who favor Pfizer's Sutent indicate that they would switch to an emerging therapy only if it extended progression-free survival (PFS) by at least an additional two to three months, assuming the agent's safety and tolerability profile was comparable to that of Sutent.
Researchers at the University of Massachusetts Medical School have described a previously unknown role for the cilia protein IFT88 in mitosis, the process by which a dividing cell separates its chromosomes containing the cell's DNA into two identical sets of new daughter cells.
› Verified 8 days ago